ARVN
ARVINAS INC
Health Care·Pharmaceuticals·UNITED STATES
$9.03
MCap $582.3M
as of 2026-08-20
Total
D8w
Fund
C2w
Quant
D2w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-08-20
MIDOS SI
-1.47
Sentiment 93.9%— long zone
−3 oversold0+3 overbought
Signal
BEARISH
Actual
$9.03
Adaptive Mean
$9.39
-0.36 vs mean
Adaptive σ
0.12
MIDOS BB
$9.14 – $9.64
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-08-21
Composite Z
-0.50
ROE
1.6%
Z -0.47
Rev Gr
1014.7%
Z -0.98
EPS Gr
—
Z +0.15
OPM Gr
384.9%
Z —
FCF Yld
-15.7%
Z -2.29
EPS Surp
10.1%
Z -0.05
EPS 3mo Δ
-86.3%
Z +0.63
Fwd P/E
-3.03
Z —
PEGY
N/A
growth + yield ≤ 0
Momentum (Risk-Adjusted Alpha)
as of 2026-08-21
Q3M
-0.56
Q6M
-8.93
Q12M
1.95
MA 30/100
0.940
Bearish (MA30 < MA100)
α (Jensen)
-0.0457
β (12M)
1.13
σ (12M)
0.548
Divergence — Fundamentals vs Momentum
Z Percentile
9%
Q Percentile
57%
Divergence
-47.2
Tier
TRIM — ACT
Momentum well ahead of fundamentals. Trim candidate.
Kirkpatrick RS & Persistence
RS
-34.7
RS Pctl
13%
RS Decile
D2
Persistence
8w
at grade D
Options / OI Analysis
No options or Williams data available for this ticker.